Neurotrauma Biomarker Research Featured in Reuters Health Medical News!

Elevated serum neurotrauma biomarkers seen with low-level occupational blast exposure

To learn how our expertise in brain biomarkers can augment your research needs.


Visit Aries Biotech at https://www.ariesbiotechnologies.org.



Originally reported in the JAMA Network Open, Neurology

“Neurotrauma Biomarker Levels and Adverse Symptoms Among Military and Law Enforcement Personnel Exposed to Occupational Overpressure”

Without Diagnosed Traumatic Brain Injury

by

Angela M. Boutté*, PhD; Bharani Thangavelu, PhD; Jeffrey Nemes, MS; Christina R. LaValle, MS; Mike Egnoto, PhD; Walter Carr, PhD; Gary H. Kamimori, PhD


https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2778573

26 views0 comments

Recent Posts

See All

Aries Biotech is pleased to announce new hours of operation! Effective 01 October 2022, hours of operation will be Monday-Thursday, 8am to 6pm (PST) by appointment. This change will help to accommod

Biomarkers for Neurological Disease and Dementia Aries Biotech and Neurovations are merging their expertise in research and development to measure biomarkers of dementia. Additional information for N